Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1

Roberto Di Fabio, Christian Marcotulli, Alessandra Tessa, Luca Leonardi, Eugenia Storti, Francesco Pierelli, Filippo M. Santorelli, Carlo Casali

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pathogenic mutations in CYP7B1 account for SPG5, an autosomal recessive hereditary spastic paraplegia characterized by a complex phenotype including visual problems and cerebellar dysfunction. Sensory ataxia is not usually regarded as a typical clinical feature of SPG5. The purpose of this study was to describe six patients showing features of sensory ataxia as the prominent and/or initial symptoms of SPG5. Six patients from three distinct pedigrees (three women, three men; age 49.5 ± 18.2 years), all presenting gait unsteadiness and frequent falls since childhood, underwent clinical and molecular investigations. All showed marked sensory ataxic gait with positive Romberg's sign, as well as severely impaired position and vibration sense. Comparatively minor signs of pyramidal involvement were also detected. In four of the patients, brain MRI showed white matter hyperintensities on T2-weighted images. An already reported homozygous c.889A>G (p.T297A) mutation in SPG5/CYP7B1 was found in five patients from two families, whereas the remaining case harbored the novel c.250-251delC/p.L84Ffs*6 and c.266A>C/p.Y89S variants. Marked and enduring sensory ataxia can be a pivotal sign in SPG5, and expands the phenotypic spectrum associated with mutations in CYP7B1.

Original languageEnglish
Pages (from-to)747-751
Number of pages5
JournalJournal of Neurology
Volume261
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Ataxia
Mutation
Gait
Hereditary Spastic Paraplegia
Cerebellar Diseases
Proprioception
Pedigree
Vibration
Phenotype
Brain

Keywords

  • Autosomal recessive
  • Hereditary spastic paraplegias
  • Sensory ataxia
  • SPG5

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1. / Di Fabio, Roberto; Marcotulli, Christian; Tessa, Alessandra; Leonardi, Luca; Storti, Eugenia; Pierelli, Francesco; Santorelli, Filippo M.; Casali, Carlo.

In: Journal of Neurology, Vol. 261, No. 4, 2014, p. 747-751.

Research output: Contribution to journalArticle

Di Fabio, R, Marcotulli, C, Tessa, A, Leonardi, L, Storti, E, Pierelli, F, Santorelli, FM & Casali, C 2014, 'Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1', Journal of Neurology, vol. 261, no. 4, pp. 747-751. https://doi.org/10.1007/s00415-014-7247-5
Di Fabio, Roberto ; Marcotulli, Christian ; Tessa, Alessandra ; Leonardi, Luca ; Storti, Eugenia ; Pierelli, Francesco ; Santorelli, Filippo M. ; Casali, Carlo. / Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1. In: Journal of Neurology. 2014 ; Vol. 261, No. 4. pp. 747-751.
@article{d32d0923c98e4c0f98d1fc3452ca8842,
title = "Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1",
abstract = "Pathogenic mutations in CYP7B1 account for SPG5, an autosomal recessive hereditary spastic paraplegia characterized by a complex phenotype including visual problems and cerebellar dysfunction. Sensory ataxia is not usually regarded as a typical clinical feature of SPG5. The purpose of this study was to describe six patients showing features of sensory ataxia as the prominent and/or initial symptoms of SPG5. Six patients from three distinct pedigrees (three women, three men; age 49.5 ± 18.2 years), all presenting gait unsteadiness and frequent falls since childhood, underwent clinical and molecular investigations. All showed marked sensory ataxic gait with positive Romberg's sign, as well as severely impaired position and vibration sense. Comparatively minor signs of pyramidal involvement were also detected. In four of the patients, brain MRI showed white matter hyperintensities on T2-weighted images. An already reported homozygous c.889A>G (p.T297A) mutation in SPG5/CYP7B1 was found in five patients from two families, whereas the remaining case harbored the novel c.250-251delC/p.L84Ffs*6 and c.266A>C/p.Y89S variants. Marked and enduring sensory ataxia can be a pivotal sign in SPG5, and expands the phenotypic spectrum associated with mutations in CYP7B1.",
keywords = "Autosomal recessive, Hereditary spastic paraplegias, Sensory ataxia, SPG5",
author = "{Di Fabio}, Roberto and Christian Marcotulli and Alessandra Tessa and Luca Leonardi and Eugenia Storti and Francesco Pierelli and Santorelli, {Filippo M.} and Carlo Casali",
year = "2014",
doi = "10.1007/s00415-014-7247-5",
language = "English",
volume = "261",
pages = "747--751",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "4",

}

TY - JOUR

T1 - Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1

AU - Di Fabio, Roberto

AU - Marcotulli, Christian

AU - Tessa, Alessandra

AU - Leonardi, Luca

AU - Storti, Eugenia

AU - Pierelli, Francesco

AU - Santorelli, Filippo M.

AU - Casali, Carlo

PY - 2014

Y1 - 2014

N2 - Pathogenic mutations in CYP7B1 account for SPG5, an autosomal recessive hereditary spastic paraplegia characterized by a complex phenotype including visual problems and cerebellar dysfunction. Sensory ataxia is not usually regarded as a typical clinical feature of SPG5. The purpose of this study was to describe six patients showing features of sensory ataxia as the prominent and/or initial symptoms of SPG5. Six patients from three distinct pedigrees (three women, three men; age 49.5 ± 18.2 years), all presenting gait unsteadiness and frequent falls since childhood, underwent clinical and molecular investigations. All showed marked sensory ataxic gait with positive Romberg's sign, as well as severely impaired position and vibration sense. Comparatively minor signs of pyramidal involvement were also detected. In four of the patients, brain MRI showed white matter hyperintensities on T2-weighted images. An already reported homozygous c.889A>G (p.T297A) mutation in SPG5/CYP7B1 was found in five patients from two families, whereas the remaining case harbored the novel c.250-251delC/p.L84Ffs*6 and c.266A>C/p.Y89S variants. Marked and enduring sensory ataxia can be a pivotal sign in SPG5, and expands the phenotypic spectrum associated with mutations in CYP7B1.

AB - Pathogenic mutations in CYP7B1 account for SPG5, an autosomal recessive hereditary spastic paraplegia characterized by a complex phenotype including visual problems and cerebellar dysfunction. Sensory ataxia is not usually regarded as a typical clinical feature of SPG5. The purpose of this study was to describe six patients showing features of sensory ataxia as the prominent and/or initial symptoms of SPG5. Six patients from three distinct pedigrees (three women, three men; age 49.5 ± 18.2 years), all presenting gait unsteadiness and frequent falls since childhood, underwent clinical and molecular investigations. All showed marked sensory ataxic gait with positive Romberg's sign, as well as severely impaired position and vibration sense. Comparatively minor signs of pyramidal involvement were also detected. In four of the patients, brain MRI showed white matter hyperintensities on T2-weighted images. An already reported homozygous c.889A>G (p.T297A) mutation in SPG5/CYP7B1 was found in five patients from two families, whereas the remaining case harbored the novel c.250-251delC/p.L84Ffs*6 and c.266A>C/p.Y89S variants. Marked and enduring sensory ataxia can be a pivotal sign in SPG5, and expands the phenotypic spectrum associated with mutations in CYP7B1.

KW - Autosomal recessive

KW - Hereditary spastic paraplegias

KW - Sensory ataxia

KW - SPG5

UR - http://www.scopus.com/inward/record.url?scp=84898885969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898885969&partnerID=8YFLogxK

U2 - 10.1007/s00415-014-7247-5

DO - 10.1007/s00415-014-7247-5

M3 - Article

VL - 261

SP - 747

EP - 751

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 4

ER -